Skip to main content
Tech.euFundingExplorerBeta

ExpressionEdits

biotechnology company optimizing protein expression using AI and proprietary intronization technology

ExpressionEdits has raised €12M across 1 funding round from 7 investors, most recently a Seed round in May 2024. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€12M
€11,973,842
Funding rounds
1
Investors
7
distinct backers
Active since
2024-05
latest 2024-05

Funding by year

EUR raised per year
ExpressionEdits — funding by year — interactive chart.
Data table
ExpressionEdits — funding by year
2024€12M

Signals

High confidence
Raise-next likelihood10
base rate 44% for Seed
  • ▼ Past typical raise window
  • ▼ Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round

Related news

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData